Literature DB >> 6491903

Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability.

G M Grass, J R Robinson.   

Abstract

Current understanding of the mechanism of corneal penetration by organic molecules proposes the epithelial layer as the rate-limiting membrane for water-soluble compounds and the stromal layer as rate limiting for lipid-soluble compounds. This suggests that the relationship between corneal permeability and the logarithm of oil/water partition coefficients, for a series of drugs, should not be the typical, single, continuous, parabolic-shaped curve. Corneal penetration studies have been conducted in unanesthetized albino rabbits using various organic compounds, representing five orders of magnitude in partition coefficient, at a constant concentration of 4 X 10(-5) M dispensed in either a 1- or 90-centipoise (cps) solution. It has been shown that for non-ionizable compounds, a pair of bell-shaped curves were generated, one for lipid-soluble and one for water-soluble compounds. Small water-soluble species demonstrate very high apparent permeabilities, which may relate to the presence of aqueous pores or other paracellular drug movement. Penetration of ionizable compounds does not appear to correlate well with the structural relationships invoked for un-ionized compounds. Consistent with the proposed mechanisms of corneal penetration, oil-soluble drug substances show no improvement in drug bioavailability when dosed from a 90-cps solution, and water-soluble drugs show a modest improvement in ocular drug bioavailability. Small water-soluble substances demonstrate no improvement due to their already high bioavailability. The importance of nonproductive absorption and precorneal drainage on bioavailability is addressed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6491903     DOI: 10.1002/jps.2600730803

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  13 in total

1.  Catanionic drug-surfactant mixtures: phase behavior and sustained release from gels.

Authors:  Tobias Bramer; Mattias Paulsson; Katarina Edwards; Katarina Edsman
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

Review 2.  [Therapy and prognosis of bacterial keratitis].

Authors:  W Behrens-Baumann; U Pleyer
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

Review 3.  Treatment of ocular infections with topical antibacterials.

Authors:  J P Leeming
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

Review 4.  Clinical pharmacokinetics of various topical ophthalmic delivery systems.

Authors:  J P Frangie
Journal:  Clin Pharmacokinet       Date:  1995-08       Impact factor: 6.447

5.  Role of enzymatic lability in the corneal and conjunctival penetration of timolol ester prodrugs in the pigmented rabbit.

Authors:  D S Chien; H Sasaki; H Bundgaard; A Buur; V H Lee
Journal:  Pharm Res       Date:  1991-06       Impact factor: 4.200

6.  Ocular pharmacokinetic models of clonidine-3H hydrochloride.

Authors:  C H Chiang; R D Schoenwald
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

7.  Effect of formulation factors on in vitro transcorneal permeation of voriconazole from aqueous drops.

Authors:  Biswaranjan Mohanty; Sagar Kumar Mishra; Dipak K Majumdar
Journal:  J Adv Pharm Technol Res       Date:  2013-10

Review 8.  Nanostructure-based platforms-current prospective in ophthalmic drug delivery.

Authors:  Rakesh Kumar Sharma; Alaa Eldeen B Yassin
Journal:  Indian J Ophthalmol       Date:  2014-07       Impact factor: 1.848

9.  Design, formulation, and evaluation of novel sustain release bioadhesive in-situ gelling ocular inserts of ketorolac tromethamine.

Authors:  Jayesh K Jethava; Gaurang K Jethava
Journal:  Int J Pharm Investig       Date:  2014-10

Review 10.  Nonionic surfactant vesicles in ocular delivery: innovative approaches and perspectives.

Authors:  Ranjan Ku Sahoo; Nikhil Biswas; Arijit Guha; Nityananda Sahoo; Ketousetuo Kuotsu
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.